Blood Pressure Lowering Effect of Transcutaneous Electrical Nerve Stimulation (HyperTENSion)
Primary Purpose
Hypertension
Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
transcutaneous electrical nerve stimulation
felodipin
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension focused on measuring randomized, cross-over, transcutaneous electrical nerve stimulation, felodipin, hypertension, blood pressure, treatment
Eligibility Criteria
Inclusion Criteria:
- clinical diagnosis of hypertension, untreated or currently treated with a maximum of one blood pressure (BP) lowering agent
Exclusion Criteria:
- systolic blood pressure >170 mmHg and/or diastolic blood pressure of >105 mmHg
- second- or third-degree atrioventricular block
- current use of opiates or other intoxicants
- neurological disorders (such as Parkinson's disease, multiple sclerosis or peripheral neuropathy)
- need of treatment with TENS, regardless the reason
Sites / Locations
- Department of Medicine, Geriatrics and Emergency Medicine, Sahlgrenska University Hospital/Östra
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
transcutaneous electr. nerve stimulation
felodipin
Arm Description
Outcomes
Primary Outcome Measures
Blood pressure reduction
Office blood pressure measurement and 24-h ambulatory blood pressure monitoring after four week periods of treatment in a cross-over design with intervening four week washout and subsequent four week follow-up
Secondary Outcome Measures
Full Information
NCT ID
NCT01390701
First Posted
July 7, 2011
Last Updated
July 7, 2011
Sponsor
Sahlgrenska University Hospital, Sweden
1. Study Identification
Unique Protocol Identification Number
NCT01390701
Brief Title
Blood Pressure Lowering Effect of Transcutaneous Electrical Nerve Stimulation
Acronym
HyperTENSion
Official Title
Blood Pressure Lowering Effect of Low-frequency Transcutaneous Electrical Nerve Stimulation and Felodipin
Study Type
Interventional
2. Study Status
Record Verification Date
June 2011
Overall Recruitment Status
Completed
Study Start Date
January 2008 (undefined)
Primary Completion Date
September 2009 (Actual)
Study Completion Date
September 2009 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Sahlgrenska University Hospital, Sweden
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to compare the blood pressure reducing property of transcutaneous electrical nerve stimulation with the blood pressure reducing drug felodipin.
Detailed Description
Hypertension is a major risk factor for development of several vascular complications and is common world wide. Drug treatment is often necessary to achieve adequate blood pressure reduction but blood pressure control in studied countries is unsatisfactory low. Reasons for failure in treatment are several. Among others reasons intolerable side-effects may prevent successful treatment irrespective of the number of drugs.
Transcutaneous electrical nerve stimulation (TENS) constitutes no risk of interaction with pharmacological agents and previous studies have reported blood pressure reduction.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
randomized, cross-over, transcutaneous electrical nerve stimulation, felodipin, hypertension, blood pressure, treatment
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
41 (Actual)
8. Arms, Groups, and Interventions
Arm Title
transcutaneous electr. nerve stimulation
Arm Type
Experimental
Arm Title
felodipin
Arm Type
Active Comparator
Intervention Type
Device
Intervention Name(s)
transcutaneous electrical nerve stimulation
Other Intervention Name(s)
2 Hz Primo Pro stimulators (CefarCompex, Sweden).
Intervention Description
30 min of bi-daily low-frequency transcutaneous electrical nerve stimulation on the upper extremities. Duration: 28+-4 days.
Intervention Type
Drug
Intervention Name(s)
felodipin
Intervention Description
2,5mg of felodipin once daily. Duration: 28+-4 days.
Primary Outcome Measure Information:
Title
Blood pressure reduction
Description
Office blood pressure measurement and 24-h ambulatory blood pressure monitoring after four week periods of treatment in a cross-over design with intervening four week washout and subsequent four week follow-up
Time Frame
four weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
clinical diagnosis of hypertension, untreated or currently treated with a maximum of one blood pressure (BP) lowering agent
Exclusion Criteria:
systolic blood pressure >170 mmHg and/or diastolic blood pressure of >105 mmHg
second- or third-degree atrioventricular block
current use of opiates or other intoxicants
neurological disorders (such as Parkinson's disease, multiple sclerosis or peripheral neuropathy)
need of treatment with TENS, regardless the reason
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jonas Silverdal, MD
Organizational Affiliation
Department of Medicine, Geriatrics and Emergency Medicine, Sahlgrenska University Hospital/Östra
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Karin Manhem, ass.prof.
Organizational Affiliation
Institute of Medicine, Department of Emergency and Cardiovascular Medicine, Sahlgrenska University Hospital/Sahlgrenska
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Clas Mannheimer, professor
Organizational Affiliation
Multidisciplinary Pain Center, Sahlgrenska University Hospital/Östra
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Georgios Mourtzinis, MD
Organizational Affiliation
Department of Medicine, Sahlgrenska University Hospital/Mölndal
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Elisabet Stener-Victorin, ass.prof.
Organizational Affiliation
Institute of Neuroscience and Physiology, Department of Physiology, University of Gothenburg
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Medicine, Geriatrics and Emergency Medicine, Sahlgrenska University Hospital/Östra
City
Göteborg
Country
Sweden
12. IPD Sharing Statement
Learn more about this trial
Blood Pressure Lowering Effect of Transcutaneous Electrical Nerve Stimulation
We'll reach out to this number within 24 hrs